A12 Predictors of treatment failure among Irish individuals infected with hepatitis C virus

@inproceedings{Dean2017A12PO,
  title={A12 Predictors of treatment failure among Irish individuals infected with hepatitis C virus},
  author={Jonathan A Dean and Maria Neary and Suzie Coughlan and C. F. De Gascun},
  booktitle={Virus evolution},
  year={2017}
}
Currently approved neuraminidase inhibitors (NAI) for the treatment of influenza A virus infections are prone to induce viral drug resistance development due to the rapid evolutionary dynamics of the neuraminidase (NA) and hemagglutinin (HA) proteins. Both HA and NA proteins are subject to antigenic drift and the epistatic interactions within and between… CONTINUE READING